Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 2/20 | 0.52 |
| ▸ | CA12 | O43570 | 3/20 | 0.50 |
| ▸ | CA1 | P00915 | 3/20 | 0.50 |
| ▸ | CA2 | P00918 | 3/20 | 0.50 |
| ▸ | CA9 | Q16790 | 3/20 | 0.50 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.50 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.50 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.50 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.50 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.50 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.50 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.46 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5399851 | 1.00 | POLB (0.52) | POLBCA12CA1CA2CA9 | |
| SCHEMBL5407485 | 0.88 | CYP1A2 (0.48) | CA12CA1CA2CA9MEN1 | |
| SCHEMBL5403997 | 0.88 | CYP1A2 (0.48) | CA12CA1CA2CA9MEN1 | |
| SCHEMBL5392843 | 0.85 | LMNA (0.46) | CA12CA1CA2CA9MEN1 | |
| SCHEMBL5392841 | 0.85 | LMNA (0.46) | CA12CA1CA2CA9MEN1 | |
| SCHEMBL5405829 | 0.85 | TSHR (0.50) | POLBCA12CA1CA2CA9 | |
| SCHEMBL5407602 | 0.85 | TSHR (0.50) | POLBCA12CA1CA2CA9 | |
| Alanine SCHEMBL9710982 | 0.81 | SLC1A3 (0.50) | CA12CA1CA2CA9CYP3A4 | |
| Alanine SCHEMBL11034209 | 0.81 | SLC1A3 (0.50) | CA12CA1CA2CA9CYP3A4 | |
| Sulfuric Acid SCHEMBL10354951 | 0.77 | TP53 (0.47) | CA12CA1CA2CA9GRIN2D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7205433-B2 | Crystal of amino acid ester salt and process for producing the same | AJINOMOTO CO., INC. (JP) | 2007-04-17 | — | — | US | disclosed |
| US-20050197396-A1 | Crystal of amino acid ester salt and process for producing the same | AJINOMOTO CO. INC (JP) | 2005-09-08 | — | — | US | disclosed |
| EP-1541546-A1 | CRYSTAL OF AMINO ACID ESTER SALT AND PROCESS FOR PRODUCING THE SAME | Ajinomoto Co., Inc. (JP) | 2005-06-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050197396-A1 | Crystal of amino acid ester salt and process for producing the same | SLC43A1, AAAS, AARS1 | POLB 3473/4885CA12 195/4885CA1 107/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.